“…However, since the initial symptoms of periodontal diseases are often mild and tolerable, diagnostic schemes requiring patients to visit clinics rather than self‐testing may often lead to inadequate patients for long‐term follow‐up (Echeverría et al, 2019). In addition, current periodontal classifications are mainly based on diagnostic methods that reflect findings at the gross/histological level, but the most significant biological events have been proven to first occur at the molecular level (Liu et al, 2022). The molecular‐level evidence of the MIF role in periodontal disease (Table 1) may have the potential to eliminate the above‐mentioned disadvantages in large‐scale screening or patient self‐testing, which enhances patient adherence and compliance and, in turn, improves periodontal disease‐related outcomes (Ganganna et al, 2020; Grande et al, 2020; Heidari et al, 2017; Li et al, 2013; Lira‐Junior et al, 2017; Ortiz‐García et al, 2019; Yilmaz et al, 2021; Zhang et al, 2021).…”